SCHEMBL28485655

SCHEMBL28485655

NC(=O)c1nc2cccc(Br)n2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ NUDT1 P36639 2/20 0.35
▸ PARP1 P09874 10/20 0.34
▸ PARP2 Q9UGN5 3/20 0.34
▸ PARP3 Q9Y6F1 3/20 0.34
▸ CYP11B2 P19099 1/20 0.32
▸ PLK4 O00444 1/20 0.32
▸ CHEK1 O14757 1/20 0.32
▸ AURKA O14965 1/20 0.32
▸ DAPK3 O43293 1/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ RET P07949 1/20 0.32
▸ FGFR1 P11362 1/20 0.32
▸ PDGFRA P16234 1/20 0.32
▸ LTK P29376 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ MAP2K2 P36507 1/20 0.32
▸ FLT3 P36888 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18341116 0.85 AHR (0.49) AHRNUDT1CYP11B2KDM4E
SCHEMBL22439076 0.80 KDM4E (0.43) L3MBTL1NUDT1PARP1CYP11B2AURKA
SCHEMBL2730240 0.78 NUDT1 (0.62) L3MBTL1NUDT1PARP1MAP2K1CLK4
SCHEMBL19658956 0.76 PARP1 (0.39) L3MBTL1NUDT1PARP1PARP2PARP3
SCHEMBL19658973 0.76 L3MBTL1 (0.36) L3MBTL1NUDT1PARP1PARP2PARP3
SCHEMBL19659614 0.76 KDM4E (0.43) L3MBTL1PARP1KDM4EALDH1A1MAPK1
SCHEMBL23754204 0.76 ADORA3 (0.49) L3MBTL1ALDH1A1MAPK1
SCHEMBL19658700 0.75 NUDT1 (0.38) NUDT1PARP1
SCHEMBL3303680 0.73 JAK2 (0.49) AHRAURKAPTK2ROCK1LRRK2
SCHEMBL23754239 0.73 SMN1; SMN2 (0.46) AHRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111499630-A Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders 加拉帕戈斯股份有限公司 2020-08-07 — — CN disclosed
Send feedback